NJK14047


CAS No. : 1800576-41-3

1800576-41-3
Price and Availability of CAS No. : 1800576-41-3
Size Price Stock
100 mg Get quote
250 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-120225
M.Wt: 445.51
Formula: C27H27NO5
Purity: >98 %
Solubility: 10 mM in DMSO
Introduction of 1800576-41-3 :

NJK14047 inhibits p38 MAPK and the differentation of naive T-cells to Th1 and Th17 cells. NJK14047 ameliorates the collage-induced rheumatoid arthritis and Imiquimod (HY-B0180)-induced psoriasis in mice[1]. In Vitro:NJK14047 (3-10 μM) inhibits expressions of inflammatory cytokines IL-1β, TNF-α, IL-6, IL-17A, RANKL, and MMP-3 in Lipopolysaccharid (HY-D1056) stimulated human SW982 synovial cells[1].
NJK14047 (3-10 μM) inhibits the differentation of naive CD4+T cells into Th1, Th2 and Th17 cells in a dose-dependent manner[1]. In Vivo:NJK14047 (2.5 mg/kg, i.p. for 7-21 days) ameliorates the collage-induced rehumatoid arthritis (CIA) in DBA-1J mice and Imiquimod (HY-B0180)-induced psoriasis (IIP) in BALB/c mice, suppresses the cytokines expressions of Th1, Th2, Th17 and Treg[1].

Your information is safe with us.